Showing 3 of 3 recruiting trials for “MITF-related melanoma and renal cell carcinoma predisposition syndrome”
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
👨⚕️ Gwenaëlle GRAVIS-MESCAM, MD, Institut Paoli Calmettes, Marseille📍 40 sites📅 Started Mar 2022View details ↗
RecruitingNCT05785052 ↗
Biomarkers of Renal Cancer
RecruitingNCT00001238 ↗
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
👨⚕️ W. Marston Linehan, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Dec 1990View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →